U.S. Stock News

NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

MannKind (MNKD) Margin Compression To 1.7% TTM Net Margin Fuels Bearish Narratives

MannKind (MNKD) has wrapped up FY 2025 with fourth quarter revenue of US$112 million and a basic EPS loss of US$0.05, setting a clear focal point for investors watching how its income statement is evolving. Over recent periods the company has seen revenue move from US$70 million in Q3 2024 to US$82 million in Q3 2025, while quarterly EPS has ranged from US$0.04 in Q1 2025 to a small profit of US$0.03 in Q3 2025 before this latest loss. This puts the spotlight firmly on how durable its margins...
NYSE:ALEX
NYSE:ALEXREITs

Alexander & Baldwin (ALEX) Q4 FFO Loss Challenges Bullish Hawaii REIT Narratives

Alexander & Baldwin (ALEX) has wrapped up FY 2025 with fourth quarter revenue of US$43.8 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$206.7 million and EPS of US$0.89. Over the last six quarters, the company has seen quarterly revenue move from US$63.2 million in Q4 2024 to US$56.8 million in Q1 2025 and down to US$43.8 million in Q4 2025, while quarterly EPS moved from US$0.18 to US$0.29 and then US$0.05. This sets up a mixed backdrop for a stock trading at...
NYSE:ALTG
NYSE:ALTGTrade Distributors

Alta Equipment Group Q4 Losses Deepen Concerns Around Bullish Margin Narratives

Alta Equipment Group (ALTG) has reported fourth quarter FY 2025 revenue of US$509.1 million with a basic EPS loss of US$0.39, setting the tone for a year where the business stayed focused on scale while earnings remained in the red. The company has seen quarterly revenue move from US$448.8 million in Q3 2024 to US$498.1 million in Q4 2024, then to US$423.0 million in Q1 2025 and up to US$509.1 million in Q4 2025, while basic EPS over that stretch ranged from a loss of US$0.34 to a loss of...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) TTM Loss Of US$661 Million Tests Bullish Margin Improvement Narrative

TeraWulf (WULF) closed FY 2025 with Q4 revenue of US$35.8 million and a basic EPS loss of US$0.30, alongside a trailing twelve month revenue base of US$168.5 million and a full year EPS loss of US$1.66. Over the last six reported quarters, revenue has ranged from US$27.1 million in Q3 2024 to US$50.6 million in Q3 2025, while quarterly basic EPS losses have moved between US$0.05 and US$1.13. This gives investors a clear picture of a business still working through heavy losses. With trailing...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

C4 Therapeutics (CCCC) Quarterly Loss Narrows To US$20.5m Challenging Persistent Bearish Narratives

C4 Therapeutics (CCCC) just posted its FY 2025 Q4 numbers, with revenue of US$11.0 million and a quarterly loss translating to basic EPS of US$0.18, set against a trailing twelve month loss of US$105.0 million and EPS of US$1.27 on revenue of US$35.9 million. Over recent quarters, the company has seen revenue move between US$5.2 million and US$15.4 million, while quarterly EPS has ranged from US$0.35 to US$0.49 and quarterly losses from US$24.7 million to US$34.6 million. The key question for...
NasdaqGM:GDEN
NasdaqGM:GDENHospitality

Golden Entertainment (GDEN) Loss Deepens In Q4 EPS Miss Challenges Profit-Recovery Narrative

Golden Entertainment (GDEN) has wrapped up FY 2025 with Q4 revenue of US$155.6 million and a basic EPS loss of US$0.33, alongside net income excluding extra items of a US$8.5 million loss. Over recent periods, the company has seen quarterly revenue move between US$154.8 million and US$164.2 million, while EPS has swung from a profit of US$0.18 in Q3 2024 to a loss of US$0.33 in Q4 2025. This leaves investors watching how quickly margins can stabilize from here. See our full analysis for...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab (RKLB) Q4 Loss Of US$52.9 Million Tests Profitability Narratives

Rocket Lab (RKLB) has just put fresh numbers on the table for FY 2025, reporting Q4 revenue of US$179.7 million and a basic EPS loss of US$0.09, alongside trailing 12 month revenue of US$601.8 million and a full year EPS loss of US$0.37. The company’s quarterly revenue moved from US$132.4 million in Q4 2024 to US$179.7 million in Q4 2025, while quarterly EPS losses ranged between US$0.10 and US$0.13 across FY 2025. As a result, the focus for investors is on how quickly those losses can be...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

ICF International (ICFI) Margin Compression Challenges Long Term EPS Growth Narrative

ICF International (ICFI) closed out FY 2025 with Q4 revenue of US$443.7 million and basic EPS of US$0.95, alongside trailing twelve month revenue of about US$1.9 billion and EPS of US$5.0 that frame the latest print against a full year backdrop. Over recent quarters, the company has seen revenue move from US$516.9 million in Q3 2024 to US$487.6 million in Q1 2025 and US$443.7 million in Q4 2025, while basic EPS shifted from US$1.74 to US$1.45 and then to US$0.95. This sets up a results season...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Globalstar (GSAT) Losses Narrow Sharply Which Reinforces Bullish Profitability Narratives

Globalstar (GSAT) has released its FY 2025 numbers, reporting Q4 revenue of US$72 million and a basic EPS loss of US$0.11. On a trailing twelve month basis, revenue came in at US$273 million and basic EPS was a loss of US$0.15. Over recent periods, the company has seen quarterly revenue range from US$60 million to US$74 million and basic EPS swing between a profit of US$0.13 and losses of up to US$0.42. This gives a clear view of how volatile margins have been as the business works through...
NYSE:MPT
NYSE:MPTHealth Care REITs

FFO Recovery At Medical Properties Trust (MPW) Challenges Bearish Cash Flow Narratives

Latest Earnings Snapshot Medical Properties Trust (MPW) has wrapped up FY 2025 with fourth quarter revenue of US$294.5 million, basic EPS of US$0.03, and Funds From Operations of US$115.9 million, giving investors a cleaner read on cash based performance for a healthcare REIT. The company has seen revenue move from US$247.5 million in Q3 2024 to US$234.8 million in Q4 2024 and then to US$294.5 million in Q4 2025. Basic EPS shifted from a loss of US$0.69 in Q4 2024 to a loss of US$0.20 in Q1...
NYSE:VTEX
NYSE:VTEXIT

VTEX NYSE VTEX Margin Expansion Reinforces Bullish Earnings Narrative After FY 2025 Results

VTEX (NYSE:VTEX) closed out FY 2025 with Q4 revenue of US$68.0 million and basic EPS of US$0.06, alongside net income of US$9.8 million. On a trailing twelve month basis, revenue was US$240.5 million with basic EPS of US$0.11 and net income of US$20.0 million. The company reported quarterly revenue moving from US$54.2 million in Q1 2025 to US$68.0 million in Q4 and basic EPS increasing from US$0.00 in Q1 to US$0.06 in Q4, indicating higher quarterly earnings contributions across the year...
NYSE:AGO
NYSE:AGOInsurance

Assured Guaranty (AGO) Net Margin Surge Challenges Bearish Earnings Narratives

Assured Guaranty’s FY 2025 Earnings Snapshot Assured Guaranty (AGO) has rounded out FY 2025 with fourth quarter revenue of US$235 million and basic EPS of US$2.55. Trailing twelve month figures show revenue of US$935 million and EPS of US$10.33, alongside earnings growth of 33.8% over the past year. Over recent quarters the company has seen revenue move from US$289 million in Q1 2025, with EPS of US$3.50, to US$198 million in Q2, US$213 million in Q3, and US$235 million in Q4, as trailing net...
NYSE:KNSL
NYSE:KNSLInsurance

Insider Sale And Cooling Growth Reframe Kinsale Capital Group Outlook

A Kinsale Capital Group (NYSE:KNSL) board director recently sold shares, drawing fresh attention to insider activity at the company. Management has flagged moderating premium growth and increasing competition in its core markets. Together, these updates point to a changing operating backdrop that investors are now reassessing. Kinsale Capital Group, trading at $389.67 as of the last close, comes into this news with a mixed recent record. The stock is up 4.4% over the past week, flat over...
NasdaqGS:EXFY
NasdaqGS:EXFYSoftware

Expensify (EXFY) Margins Under Pressure As Q4 Loss Widens Despite Stable Revenue

Expensify FY 2025 results set the stage for a margin story investors will be watching closely Expensify (EXFY) has laid out a challenging FY 2025 finish, with Q4 revenue of about US$35.2 million alongside a basic EPS loss of US$0.08 and net income excluding extra items showing a loss of US$7.1 million. Over recent periods the company has seen quarterly revenue move from US$37.0 million in Q4 FY 2024 to the US$35 million to US$36 million range across FY 2025. Basic EPS has stayed in loss...
NasdaqGS:FOXF
NasdaqGS:FOXFAuto Components

Fox Factory Holding (FOXF) Q4 EPS Loss Deepens Recovery Debate Despite Stable Revenue

Fox Factory Holding (FOXF) has released its FY 2025 numbers with Q4 total revenue of US$361.1 million and a basic EPS loss of US$6.86, while trailing twelve month figures show revenue of US$1.5 billion and a basic EPS loss of US$13.03. The company’s total revenue increased from US$352.8 million in Q4 2024 to US$361.1 million in Q4 2025, while basic EPS moved from a small loss of US$0.00 to a much larger loss of US$6.86 over the same period, setting up a results season in which margins and the...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) TTM Loss Of US$465 Million Tests Bullish Long Term Narratives

Crinetics Pharmaceuticals (CRNX) closed out FY 2025 with Q4 revenue of US$6.2 million and a basic EPS loss of US$1.29, alongside a full year trailing basic EPS loss of US$4.95 on revenue of US$7.7 million. Over recent quarters the company has seen quarterly revenue move from US$0.14 million in Q3 2025 and US$1.03 million in Q2 2025 to US$6.2 million in Q4 2025, while quarterly basic EPS losses ranged between US$1.04 and US$1.38 per share across FY 2025. This provides context for investors as...
NasdaqGM:PUBM
NasdaqGM:PUBMMedia

PubMatic (PUBM) Q4 Profit Return Challenges Bearish Narratives On Persistent Losses

PubMatic (PUBM) closed out FY 2025 with Q4 revenue of US$80.0 million and basic EPS of US$0.14, alongside trailing twelve month revenue of US$282.9 million and a basic EPS loss of US$0.31. Over recent quarters, the company has seen quarterly revenue move from US$63.8 million in Q1 2025 to US$80.0 million in Q4 2025, while basic EPS shifted from a loss of US$0.20 in Q1 to a profit of US$0.14 in Q4. For investors, the mix of improving quarterly EPS against a still loss making twelve month...
NasdaqGM:JANX
NasdaqGM:JANXBiotechs

Janux Therapeutics JANX Net Loss Deepens To US$113.6 Million Challenging Bullish Growth Narratives

Janux Therapeutics (JANX) closed out FY 2025 with Q4 revenue of US$0 and a basic EPS loss of US$0.51, keeping the focus squarely on how efficiently it is funding and progressing its pipeline rather than on top line growth. The company has seen quarterly revenue move between US$0 and US$10 million over the past year, while basic EPS losses have ranged from US$0.38 to US$0.55 per share. This sets up a story in which any potential upside depends heavily on whether management can convert this...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp (NTAP) Margin Improvement Reinforces Bullish Profitability Narrative In Q3 2026

NetApp (NTAP) has put another solid quarter on the board, with Q3 2026 revenue of US$1.7 billion, basic EPS of US$1.69 and trailing twelve month EPS of US$6.08 helping frame how the latest print fits into its recent performance. The company has seen revenue move from US$1.66 billion in Q2 2025 to US$1.71 billion in Q3 2026, while quarterly basic EPS has ranged between US$1.16 and US$1.69 over that period. This sets up a story where a stable top line and consistent earnings keep margins firmly...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives

Aurinia Pharmaceuticals (AUPH) closed FY 2025 with Q4 revenue of US$77.1 million and basic EPS of US$1.60, alongside trailing twelve month EPS of US$2.14 on revenue of US$283.1 million. This frames a very strong headline earnings story. Over the past few quarters, the company has seen revenue move from US$59.9 million in Q4 2024 to US$77.1 million in Q4 2025, while quarterly EPS shifted from roughly breakeven at US$0.01 to US$1.60, with trailing twelve month net income reaching US$287.2...
NasdaqGM:VITL
NasdaqGM:VITLFood

Vital Farms (VITL) Earnings Growth Of 24.2% Tests Market Skepticism On Profit Quality

Vital Farms (VITL) has just wrapped up FY 2025 with fourth quarter revenue of US$213.6 million and basic EPS of US$0.36, alongside full year trailing twelve month EPS of US$1.49 on revenue of US$759.4 million. Earnings for the past year have been reported as growing 24.2%. The company has seen quarterly revenue move from US$145.0 million in Q3 2024 to US$165.9 million in Q4 2024, then to US$162.2 million, US$184.8 million, US$198.9 million and finally US$213.6 million through FY 2025. Over...
NYSE:NP
NYSE:NPInsurance

Neptune Insurance Holdings (NP) Trailing Loss Challenges Bullish High Margin Narratives

Neptune Insurance Holdings (NP) closed FY 2025 with Q4 revenue of US$43.8 million and basic EPS of US$0.03, set against trailing 12 month revenue of US$159.6 million and a basic EPS loss of US$0.26. The company has seen quarterly revenue move from US$31.5 million in Q4 2024 to US$43.8 million in Q4 2025. Basic EPS has ranged from a loss of US$0.21 in Q1 2025 to US$0.06 in the year earlier quarter, leaving investors weighing solid top line progress against margins that are still under...
NYSE:DSX
NYSE:DSXShipping

Diana Shipping (NYSE:DSX) One Off US$17.3m Gain Challenges Earnings Quality Narrative

Diana Shipping (NYSE:DSX) has just wrapped up FY 2025 with fourth quarter revenue of US$52.1 million and basic EPS of US$0.02, rounding out a year where trailing twelve month revenue came in at US$213.5 million and EPS at US$0.11. Over recent periods, the company has seen quarterly revenue move between US$51.9 million and US$54.9 million, while basic EPS ranged from about US$0.01 to US$0.07. During the same timeframe, trailing twelve month EPS rose from US$0.06 to US$0.11 as revenue shifted...
NYSE:SG
NYSE:SGHospitality

Sweetgreen Q4 Loss Worsening To US$49.7 Million Tests Bullish Profitability Narrative

Sweetgreen (SG) just closed out FY 2025 with Q4 revenue of US$155.2 million and a basic EPS loss of US$0.42, while trailing 12 month revenue came in at US$679.5 million with a TTM basic EPS loss of US$1.14. Over the year, the company has seen quarterly revenue shift from US$166.3 million in Q1 and US$185.6 million in Q2 to US$172.4 million in Q3 and US$155.2 million in Q4, with basic EPS losses ranging from US$0.21 to US$0.42 per quarter. With TTM net losses still substantial and same...